Prequalify

Vitiligo Study

Vitiligo Clinical Trial

Center for Dermatology Clinical Research in Fremont, CA is conducting a new clinical study evaluating a new investigational treatment option for vitiligo. There is no placebo.  Compensation is available for qualified participants of this clinical research opportunity sponsored by Teva Pharmaceuticals. 

Study Overview

Who Qualifies? Male or female patients ages 18-75 with vitiligo

Study Duration: 24 weeks + 1 year followup

Protocol: TV53408-IMM-10209

Site Location